Smartwatches may transform blood sugar tracking, but today’s advances depend on CGMs, AI, and regulated health tech ...

Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...

Wearables now flag everything from irregular heartbeats to dips in blood oxygen, but the data is only as useful as a person's ...

A new initiative integrated personal continuous glucose monitor reports into routine primary care visits for diabetes.

As wearable technologies continue to rapidly develop, the use cases for wearable devices evolve and expand. Artificial intelligence (AI) and machine learning (ML) drive these devices and the latest ...

Continuous glucose monitors have become popular among those who need to track their glucose levels because they're painless ...

Danaher Corporation (NYSE:DHR) is one of the best non-tech stocks to buy according to analysts. Masimo, Danaher Corporation’s ...

Discover the latest on Apple’s revolutionary smart ring, including features and rumored release dates, in our comprehensive guide. Stay updated now.

On 22 June 2026, Masimo, a Danaher company, received FDA 510(k) clearance for an AI-enabled opioid-induced respiratory ...

"Masimo secures FDA approval for OIRD detection on wearable patient monitor" was originally created and published by Medical ...

Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring ...

The OIRD detection capability [Image courtesy of Masimo] Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.